Literature DB >> 10430040

Adhesion molecule expression and regulation on cells of the central nervous system.

S J Lee1, E N Benveniste.   

Abstract

Cellular adhesion molecules were initially defined as cell surface structures mediating cell-cell and cell-extracellular matrix (ECM) interactions. Adhesion molecules involved in immune responses have been classified into three families according to their structure: selectins, immunoglobulin (Ig) superfamily, and integrins. It has been well documented that adhesion molecules of these family members (E-selectin, ICAM-1, and VCAM-1) are expressed on brain microvessel endothelial cells in active lesions of multiple sclerosis (MS) brain. In addition, accumulating data show that glial cells can express some of these adhesion molecules upon activation: astrocytes can express ICAM-1, VCAM-1, and E-selectin, and microglia express ICAM-1 and VCAM-1. In vitro studies show that these adhesion molecules are actively regulated by several cytokines which have relevance to MS or experimental autoimmune encephalomyelitis (EAE). In addition, soluble forms of adhesion molecules have been found in the serum and cerebrospinal fluid (CSF) of MS patients, and may be useful diagnostically. Experimental therapy of EAE using antibodies against several adhesion molecules clearly shows that adhesion molecules are critical for the pathogenesis of EAE. Thus far, the function of adhesion molecule expression on brain endothelial and glial cells has not been clearly elucidated. Studies on the possible role of adhesion molecules on brain endothelial and glial cells will be helpful in understanding their involvement in immune responses in the central nervous system (CNS).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430040     DOI: 10.1016/s0165-5728(99)00084-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  70 in total

Review 1.  Statins as potential therapeutic agents in multiple sclerosis.

Authors:  Olaf Stüve; Thomas Prod'homme; Sawsan Youssef; Shannon Dunn; Oliver Neuhaus; Martin Weber; Hans-Peter Hartung; Lawrence Steinman; Scott S Zamvil
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

Review 2.  [Possible target specific molecular imaging with ultrasound contrast agents].

Authors:  M Mäurer; R Linker; M Reinhardt; P Hauff
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 3.  Leukocyte adhesion molecules in animal models of inflammatory bowel disease.

Authors:  Jesús Rivera-Nieves; Gezahegn Gorfu; Klaus Ley
Journal:  Inflamm Bowel Dis       Date:  2008-12       Impact factor: 5.325

Review 4.  Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.

Authors:  Xu Zhang; Raymond Hupperts; Marc De Baets
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 5.  [Blocking adhesion molecules with natalizumab in multiple sclerosis].

Authors:  B Schreiner; B C Kieseier; H-P Hartung; R Hohlfeld; H Wiendl
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

6.  Psoriasis during natalizumab treatment for multiple sclerosis.

Authors:  Jorge Millán-Pascual; Laura Turpín-Fenoll; Pablo Del Saz-Saucedo; Ignacio Rueda-Medina; Santiago Navarro-Muñoz
Journal:  J Neurol       Date:  2012-10-25       Impact factor: 4.849

Review 7.  Traumatic brain injury, neuroinflammation, and post-traumatic headaches.

Authors:  Cynthia L Mayer; Bertrand R Huber; Elaine Peskind
Journal:  Headache       Date:  2013-07-08       Impact factor: 5.887

8.  Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia.

Authors:  Jonathan Kipnis; Hila Avidan; Rachel R Caspi; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

9.  Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration.

Authors:  Jonathan Kipnis; Michal Cardon; Hila Avidan; Gil M Lewitus; Sharon Mordechay; Asya Rolls; Yael Shani; Michal Schwartz
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

10.  Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis.

Authors:  Jasmeen S Merzaban; Jaime Imitola; Sarah C Starossom; Bing Zhu; Yue Wang; Jack Lee; Amal J Ali; Marta Olah; Ayman F Abuelela; Samia J Khoury; Robert Sackstein
Journal:  Glycobiology       Date:  2015-07-07       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.